Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Conroy

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Human Heredity|January 23, 2019
Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell SequencingWendy J Huss, Qiang Hu, Sean T Glenn, et al.
Biomarker Research|July 8, 2021
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and responseSarabjot Pabla, R J Seager, Erik Van Roey, et al.
Plos One|December 2, 2021
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2015
The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiologyQianqian Zhu, Qiang Hu, Lori Shepherd, et al.
Oncotarget|December 3, 2016
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencingBenjamin E Paluch, Sean T Glenn, Jeffrey M Conroy, et al.
Frontiers in Oncology|November 15, 2024
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratoryKyle C Strickland, Mary K Nesline, Rebecca A Previs, et al.
Briefings in Bioinformatics|October 29, 2024
A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumorsZachary D Wallen, Mary K Nesline, Sarabjot Pabla, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
BMC Medical Genomics|October 21, 2016
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencingLei Wei, Antonios Papanicolau-Sengos, Song Liu, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Human Heredity|January 23, 2019
Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell SequencingWendy J Huss, Qiang Hu, Sean T Glenn, et al.
Biomarker Research|July 8, 2021
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and responseSarabjot Pabla, R J Seager, Erik Van Roey, et al.
Plos One|December 2, 2021
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2015
The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiologyQianqian Zhu, Qiang Hu, Lori Shepherd, et al.
Oncotarget|December 3, 2016
Robust detection of immune transcripts in FFPE samples using targeted RNA sequencingBenjamin E Paluch, Sean T Glenn, Jeffrey M Conroy, et al.
Frontiers in Oncology|November 15, 2024
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratoryKyle C Strickland, Mary K Nesline, Rebecca A Previs, et al.
Briefings in Bioinformatics|October 29, 2024
A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumorsZachary D Wallen, Mary K Nesline, Sarabjot Pabla, et al.
The Journal of Molecular Diagnostics : JMD|October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid TumorsJeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
BMC Medical Genomics|October 21, 2016
Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencingLei Wei, Antonios Papanicolau-Sengos, Song Liu, et al.
Pageof 7